FIELD: medicine.
SUBSTANCE: agent for preparing therapeutic and hygienic baths contains a cosmetic agent and a buffer citrate with pH=5.5, which comprises 2-hydroxy-1,2,3-propane tricarboxylic acid and trisodium salt of 2-hydroxy-1,2,3-propane tricarboxylic acid; the composition 1 litre of the said buffer citrate with pH=5.5: 2-hydroxy-1,2,3-propane tricarboxylic acid - 5.55 g, trisodium salt of 2-hydroxy-1,2,3-propane tricarboxylic acid - 35.7 g.
EFFECT: more effective treatment and prevention of atopic dermatitis by stabilising water pH and improving the adsorption properties of the cosmetic products.
2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING SKIN INFECTION BY ADMINISTERING ANTAGONIST IL-4R | 2015 |
|
RU2704999C2 |
WAY OF TREATMENT OF ATOPIC DERMATITIS | 2007 |
|
RU2361604C1 |
NEMOLIZUMAB IN TREATMENT OF ATOPIC DERMATITIS WITH MODERATE TO SEVERE EXCORIATION | 2019 |
|
RU2758378C1 |
USE OF IL-13 ANTAGONISTS FOR THE TREATMENT OF ATOPIC DERMATITIS | 2017 |
|
RU2752785C2 |
METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING IL-4R ANTAGONIST | 2013 |
|
RU2666630C2 |
METHODS OF TREATING ATOPIC DERMATITIS WITH THE HELP OF IL-4R ANTAGONIST | 2013 |
|
RU2698907C2 |
METHOD OF TREATMENT OF ATOPIC DERMATITIS THROUGH INTRODUCTION OF IL-4R INHIBITOR | 2019 |
|
RU2801204C2 |
METHOD OF TREATING ATOPIC DERMATITIS | 2011 |
|
RU2468835C1 |
METHODS OF TREATING ATOPIC DERMATITIS BY ADMINISTERING IL-4R ANTAGONIST | 2020 |
|
RU2828020C2 |
COMPOSITION COMPRISING PROBIOTIC BACTERIA OR COMPONENTS THEREOF, AND METHOD FOR USE THEREOF IN TREATING IMMUNE SKIN DISEASES | 2017 |
|
RU2699540C2 |
Authors
Dates
2015-01-10—Published
2013-07-25—Filed